OrthoXel has received FDA 510(k) clearance for the Vertex hip fracture nail, which is indicated for hip fracture fixation procedures for various fracture types and patient anatomies. Douglas R. Dirschl, MD, a professor and chair of orthopedic surgery, expressed excitement about the innovative nail providing benefits to his patients and other fracture surgeons. Dirschl was involved in the product development process and praised the Vertex nail for its enhanced stability and flexibility in tailoring treatment to individual patient and fracture needs. The OrthoXel team was commended for their excellence and innovation in product design.
Source link
OrthoXel receives FDA 510(k) clearance of hip fracture nail
